Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Arvinas Inc.
DualityBio Inc.
Bold Therapeutics, Inc.
Genfit
Apollo Therapeutics Ltd
Alentis Therapeutics AG
West China Hospital
Tango Therapeutics, Inc.
Cogent Biosciences, Inc.